Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Studies reveal tolerability and efficacy of darifenacin in overactive bladder

April 1, 2004

BXL-353 inhibits testosterone-stimulated prostate growth in vivo

March 31, 2004

Stem cell therapy effective in urinary incontinence patients

March 31, 2004

Duloxetine demonstrates efficacy in women with stress urinary incontinence

March 31, 2004

Ranbaxy patents series of novel muscarinic receptor antagonists

March 31, 2004

Positive opinion handed down in Europe for duloxetine for SUI

March 30, 2004

FibroGen research supports HIF activation technology for acute renal failure

March 30, 2004

Novel PDE5 inhibitor for erectile dysfunction by Schering Plough

March 29, 2004

Merck to discontinue development of EMR-62203

March 29, 2004

Fosrenol receives approval in Sweden

March 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...